comparemela.com

Sebastian Vogel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DOCMORRIS : Gets a Sell rating from UBS - MarketScreener

Sebastian Vogel from UBS retains his negative opinion on the stock with a Sell rating. The target price is unchanged at CHF 31.90.

Sebastian vogel

DOCMORRIS : Sell rating from UBS - MarketScreener

UBS s analyst Sebastian Vogel maintains his Sell rating on the stock. The target price remains set at CHF 31.90.

Sebastian vogel

DOCMORRIS : UBS reaffirms its Sell rating -April 02, 2024 at 06:31 am EDT

UBS analyst Sebastian Vogel reiterate his Sell rating on the stock. The target price is increased from CHF 29 to CHF 31.90.

Sebastian vogel

DOCMORRIS : UBS reiterates its Sell rating -January 16, 2024 at 03:23 am EST

In his latest research note, analyst Sebastian Vogel confirms his negative recommendation. The broker UBS is keeping its Sell rating. The target price continues to be set at CHF 29.

Sebastian vogel

DOCMORRIS : UBS keeps a Sell rating -October 20, 2023 at 07:37 am EDT

The analyst from UBS, Sebastian Vogel, maintains his advice to sell. The target price differs slightly and is now set at CHF 29.00 versus CHF 29.50.

Sebastian vogel

vimarsana © 2020. All Rights Reserved.